Related Experiment Video
Updated: Sep 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
FusionMVSA: Multi-View Fusion Strategy With Self-Attention for Enhancing Drug Recommendation
None:
Leveraging the wealth of biomedical data available, we can derive insights into the relationships between biological entities from various angles. This underscores the complexity and significance of developing a dynamic approach for integrating data from multiple sources, a critical endeavor in drug recommendation. In this study, we introduce an innovative deep learning approach termed "Multi-View Fusion Strategy with Self-Attention" (FusionMVSA), designed to predict associations between drugs and diseases. To effectively amalgamate data from diverse sources and extract representative features, we have developed a feature extraction mechanism that capitalizes on similarities. This mechanism computes self-attention across multiple perspectives using shared group parameters, thereby highlighting common characteristics. Simultaneously, we utilize biomedical similarities among multi-source data as guiding factors for calculating similarity, enabling the capture of more nuanced features. Subsequently, we integrate these features through a feature fusion process, where known associations between drugs and diseases act as guiding terms. This strategy allows us to uncover the complementary aspects of different viewpoints. Ultimately, we predict potential drug-disease associations using a multi-layer perceptron neural network. Our methodology has undergone rigorous testing through various cross-validation experiments and case studies. We are confident that FusionMVSA will prove to be a valuable tool in drug recommendation, offering new avenues for exploration and discovery in the quest to combat diseases.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug Discovery: Overview
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
